Centaurus Financial, Inc. Emergent Bio Solutions Inc. Transaction History

Centaurus Financial, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$27.42 - $43.63 $14,971 - $23,821	546 Added 14.38%	4,342 $135,000
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $22,654 - $32,428	621 Added 19.56%	3,796 $156,000
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $3,254 - $4,293	-65 Reduced 2.01%	3,175 $159,000
Q2 2021 Aug 10, 2021	SELL	$56.61 - $80.46 $347,019 - $493,219	-6,130 Reduced 65.42%	3,240 $204,000
Q1 2021 Apr 30, 2021	BUY	$86.23 - $125.19 $807,975 - $1.17 Million	9,370 New	9,370 $871,000
Q3 2018 Nov 05, 2018	SELL	$52.05 - $66.51 $104 - $133	-2 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$48.33 - $55.64 $96 - $111	2 New	2 $0

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $515M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.